Business
Pervasip Announces $1.6 Million in August Revenues and 3rd Quarter Guidance
Pervasip Announces $1.6 Million in August Revenues and 3rd Quarter Guidance.
About this update from Pervasip Corp.
[{"type":"text","content":"\n SEATTLE, WASHINGTON, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Pervasip Corp. (OTC: PVSP) (“Pervasip” or the “Company”), a developer of companies and technologies in high value emerging markets, together with Zen Asset Management, today announced that Artizen reached sales of $1.6 million in August. “Marking the best sales month ever is a testament to the hard work of the team and quality of Artizen branded products in these difficult market conditions,” says German Burtscher, Pervasip’s CEO. “August also marks the close of the 3rd quarter and the restructuring efforts of the last several months are starting to show improvement across many key financial performance indicators, including cashflow for Q3. As we further rationalize our business, including shedding of underperforming assets, we will continue to prioritize margins over revenue to build lasting financial health and strengthening fundamentals important to support our growth. We are achieving a more balanced ratio of revenues across all product categories which will serve the Company well as it goes into Q4.” The Company also reports that various new product lines and planned near-term acquisitions will add revenue, new growth opportunities, and be a springboard for expansion into other recreational cannabis markets in the US. Pervasip CorporationPervasip Corp., a developer of companies and technologies in high value emerging markets, owns Artizen Corporation and its subsidiary, Zen Asset Management LLC, a diversified asset management company founded to acquire, develop, and support companies and technologies in the cannabis industry. ZAM’s existing clients operate four licensed cannabis cultivation and one processing facility in Washington. Most of the biomass produced by these independent cultivators has been sold historically under the Artizen™ brand, including all-time top selling products in flower in Washington state. Additional information on Artizen-branded products is available online at www.artizencannabis.com. Pervasip additionally owns 5% of KRTL Biotech, Inc., a developer of biotechnologies with a focus on pharmaceutical applications of cannabinol and psilocybin. Additional information on KRTL is available online at www.krtlbiotech.com. Additional information on Pervasip can be found at www.perva...